Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2017-04-05
Product name:
UTROGESTAN
DIN:
02462818
Product Monograph/Veterinary Labelling:
Date:
2017-04-04
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BESINS HEALTHCARE S A
287 Avenue Louise, Louise Centre
Brussels
Brussels Capital Region
Belgium
1050
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Vaginal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03DA04 PROGESTERONE
Active ingredient group (AIG) number:See footnote5
0106327003
Active ingredient(s) | Strength |
---|---|
PROGESTERONE | 200 MG |